{"nct_id":"NCT00991146","title":"Efficacy and Safety Study of Canakinumab Administered for 6 Months (24 Weeks) in Japanese Patients With Cryopyrin-associated Periodic Syndromes Followed by an Extension Phase","status":"COMPLETED","status_verified_date":"2020-09","start_date":"2009-10","start_date_type":null,"primary_completion_date":"2012-02","primary_completion_date_type":"ACTUAL","completion_date":"2012-02","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["NVS"]}